During the past decade, Charles University Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Charles University Hospital" #1 sponsor was "Ipsen" with 2 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored, "Population Health Research Institute" with 1 trials sponsored, "Regeneron Pharmaceuticals" with 1 trials sponsored and "Sanofi" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Charles University Hospital" #1 collaborator was "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator, "Ankara University" with 1 trials as a collaborator, "Centre for Chronic Disease Control, India" with 1 trials as a collaborator, "Centre hospitalier de l'Université de Montréal (CHUM)" with 1 trials as a collaborator and "Charles University, Czech Republic" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Charles University Hospital" are "Acromegaly" (2 trials), "Colorectal Cancer" (1 trials), "Hypercholesterolemia" (1 trials), "Prostate Cancer" (1 trials) and "the Efficacy and Safety of Off-pump CABG" (1 trials). Many other conditions were trialed in "Charles University Hospital" in a lesser frequency.

Most popular intervention types in "Charles University Hospital" are "Drug" (5 trials), "Procedure" (2 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Background Lipid Modifying Therapy (LMT)" (1 trials), "Coronary Artery Bypass Graft with the use of CPB" (1 trials), "Coronary Artery Bypass Graft without the use of CPB" (1 trials), "Evinacumab" (1 trials) and "Lanreotide (Autogel formulation)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Charles University Hospital" are 5 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Charles University Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Charles University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Charles University Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".